Hpv
Nearly one-third of men worldwide have genital HPV
Roughly one-third of men globally have at least one type of genital HPV and one in five are infected with at least one high-risk HPV type, according to the results of a systematic review and meta-analysis.
10-year data show ‘robust’ long-term benefit of HPV vaccination
A study of 10-year follow-up data showed no cases of high-grade intraepithelial neoplasia and few cases of HPV infection among almost 1,300 boys and girls who received the 9-valent HPV vaccine, according to results published in Pediatrics.
Intralesional HPV vaccine may clear recalcitrant warts
While both bivalent and quadrivalent HPV vaccines are promising treatments for recalcitrant warts, the quadrivalent option shows a significant statistic superiority, according to a research letter.
Adolescent, young adult cancer survivors at greater risk for HPV-related malignancies
Survivors of cancer in adolescence and young adulthood face increased risk for subsequent HPV-related cancer diagnoses, according to research conducted at University of Utah’s Huntsman Cancer Institute.
Combination exhibits ‘impressive’ activity in HPV-negative head and neck cancer
The combination of ficlatuzumab and cetuximab extended PFS for patients with pan-refractory recurrent or metastatic head and neck squamous cell carcinoma, according to randomized phase 2 study results.
Reframing HPV shot as cancer vaccine improved uptake among 9-year-olds
WASHINGTON — Experts at the Pediatric Academic Societies Meeting suggested reframing conversations about HPV to encourage parents to get children vaccinated starting at age 9 years.
Awareness that HPV causes cervical cancer declines among Americans
Results of a survey study showed a decrease in the proportion of Americans who are aware that HPV causes cervical cancer, according to a presenter at American Association for Cancer Research Annual Meeting.
Mailing HPV kits effective for increasing cervical cancer screening uptake
Mailing HPV self-sampling kits to women who are overdue for cervical cancer screening was cost-effective in increasing screening uptake compared with usual care, according to an economic evaluation published in JAMA Network Open.
HPV vaccination rate improves but many parents remain hesitant
The rate of teenagers vaccinated against HPV is improving but a significant number of parents remain hesitant about their children receiving the vaccine, a study found.
Circulating tumor HPV DNA testing has limitations for diagnosis of oropharynx cancers
Circulating tumor tissue-modified viral HPV DNA detected through a new assay appeared associated with nodal disease burden among patients with HPV-positive oropharyngeal squamous cell carcinoma, according to study results.